KLOW Peptide Canada: Inside the Four-Component Research Blend
Labs that order KLOW peptide in Canada are really ordering four separate compounds packed into a single vial. That is convenient on the bench, but it changes almost everything about how the material should be specified, checked on arrival and recorded in inventory. A blend certificate answers different questions from a single-compound certificate, the storage limits are set by the most fragile ingredient, and an unexpected result is harder to trace. This guide breaks the blend down for QC staff and purchasing leads who handle it in multi-vial quantities.
KLOW peptide in Canada: what the label adds up to
The number on a KLOW vial is a total. It is the sum of four components, not the mass of any one of them, and the split is uneven. A closely related product, GLOW, uses the same recipe minus one ingredient.
| Component | KLOW 80 mg | GLOW 70 mg |
|---|---|---|
| GHK-Cu | 50 mg | 50 mg |
| BPC-157 | 10 mg | 10 mg |
| TB-500 fragment | 10 mg | 10 mg |
| KPV | 10 mg | none |
Two things stand out. The copper complex accounts for well over half of the vial in both products, and the only difference between them is the KPV tripeptide. Anyone calculating a working concentration for one component has to start from that component’s own mass, and ideally from its net peptide content, rather than from the total printed on the label.
Four molecules with little in common
These components are not a family of related sequences. They differ in size, chemistry and analytical behaviour, which is why a blend of them needs more careful characterisation than any one of them alone.
BPC-157
A synthetic fifteen-residue peptide with the sequence GEPPPGKPADDAGLV, formula C62H98N16O22, around 1,419.5 g/mol. It was derived from a partial sequence of a protein described in gastric juice. The run of three prolines near the N-terminus matters analytically: peptide bonds before proline switch slowly between cis and trans forms, so the main peak on reversed-phase HPLC can look broad or shouldered without any second substance being present. The published work on it is largely preclinical and comes from a limited number of groups.
TB-500
Often mislabelled as thymosin beta-4, TB-500 is actually a short acetylated fragment modelled on the actin-binding region of that protein, roughly residues 17 to 23. It weighs about 889 g/mol (C38H68N10O14). The parent protein runs to 43 residues and sits near 4,963 g/mol, so a mass check separates them instantly.
GHK-Cu
The tripeptide glycyl-histidyl-lysine bound to a copper(II) ion. As a complex it comes to roughly 402.9 g/mol, about 62 Da heavier than the free tripeptide, and it is correctly treated as a metal coordination compound rather than an ordinary peptide. Our article on GHK-Cu copper coordination covers the binding chemistry.
KPV
Lys-Pro-Val, the final three residues of alpha-melanocyte-stimulating hormone, at 342.43 g/mol (C16H30N4O4). In the literature it is studied as a small melanocortin-derived fragment, mostly in cell-based and other preclinical models. Be aware that database searches for the abbreviation can surface an unrelated small molecule, so confirm identity by sequence and mass.
What a clean chromatogram of the blend looks like
On a reversed-phase column, a well-characterised KLOW lot should give four resolved main peaks, each confirmed by mass spectrometry. The two tripeptides are small and polar and tend to elute early; BPC-157 and the TB-500 fragment behave differently again. A report that gives one purity number for the whole vial has not described the four components.
Detection wavelength deserves attention. None of the four components contains tryptophan or tyrosine, so absorbance at 280 nm is weak and not useful for purity work. Analysis is normally done in the low-UV region around 214 to 220 nm, where the peptide bond absorbs. Even there, each component responds differently per milligram, because a fifteen-residue chain has far more peptide bonds than a tripeptide. Peak areas across components therefore do not translate directly into a mass ratio.
Purity and ratio are separate questions
A blend certificate can confirm that each component is the correct molecule and is reasonably free of synthesis impurities, and still say nothing about whether the vial holds the stated 50:10:10:10 split. Those are distinct measurements:
- Purity is a relative figure from peak areas within each component’s region of the chromatogram.
- Composition is quantitative and needs calibrated standards for each component, or a method validated for the blend.
- Identity comes from mass spectrometry, one confirmed mass per component.
When you specify a volume order, state which of the three you need documented. For many labs, identity plus per-component purity is enough; groups that must defend a component ratio will need to ask for, or run, the quantitative work themselves.
Copper sets the storage rules
Because GHK-Cu dominates the vial by mass, the blend’s handling requirements are essentially the copper complex’s requirements. Copper(II) gives the powder its blue tint, and a noticeably uneven or off-colour cake is worth photographing and logging at receiving. Because copper(II) can shuttle electrons, the complex tolerates light, oxygen and warmth less well than the other three components do.
Practical consequences for analytical stock:
- Keep lyophilised vials cold and dark, and record the date each group goes into storage.
- Let a sealed vial reach room temperature before opening so moisture condenses on the outside of the glass, not on the powder.
- Assume the shelf life of the blend is limited by its least stable member, not by the average.
Receiving and logging a multi-vial blend order
A short, repeatable routine keeps a large KLOW order traceable over months of use:
- Confirm the product name and total mass on each vial against the packing slip.
- Match the cap and crimp colour to the certificate you are filing against, and note that pairing in the inventory log.
- Check that the certificate identifies all four components by mass, not only by name.
- Record the condition of each cake, including colour, and the temperature of the packaging on arrival.
- Transfer to cold, dark storage the same day.
Keeping a whole order within one lot where possible removes a source of variation between vials opened weeks apart.
When single vials make more sense than the blend
The main weakness of any blend is attribution. If a result in a model system looks unusual, there is no way to assign it to one component without testing the components separately. For that kind of work, researchers usually buy the individual compounds, such as BPC-157, the TB-500 fragment and GHK-Cu, and combine them at the bench. With mix-and-match volume pricing, every vial in the cart counts toward the volume break, so splitting an order into single compounds does not cost you the tier. The KLOW 80 mg and GLOW 70 mg blends remain the practical choice where the combination itself is what is being studied.
Bulk Peptides products are third-party tested for purity by HPLC, certificates are published for some products, and vials are matched to their certificate by cap and crimp colour.
KLOW, GLOW and their individual components are supplied only for in-vitro laboratory research. They are not intended for human or animal use, and this article is not guidance on any such use.
How KLOW compares with GLOW on price per mg at 10+ vials is set out in GLOW vs KLOW; all our side-by-side guides are on peptide comparisons.
